Reason for request
Re-assessment of the actual benefit at the request of the Transparency
Clinical Benefit
| Low |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
eNq1mF1v2jAUhu/5FVEudpeEtNDCllBtrN2QWo1R0KbdIJMcwCzYqT+A7tfPIXSFyVFbg69QYuf1yTnHj18SXW2WmbMCxjElsRv6ddcBktAUk1nsjoY3Xsu96tSiBVqhvWmXft0Pz1wnyRDnsVuM+hNAhPs/724/g3oemNupORGdLCARB/OkwJn/FfH5HcqLOU60ojh1liDmNI3dXIrtXSfigqkoOmvKfvMcJRAFuzv7o4txY/9+FBRir1CVHNgtIjOtKBAjzUQyBkR0kYAZZY8V8Z4baWM+AE4lS6CPxLzP6AqnkGqXmKKMg9Ei03V6D2yVgSgW0YoHi2TJjcTRAm0G8NDTB/1RjXbFRnh1L7xsnjVbzUajHl6GRkuxvVTpq6BeIkjG4UWj1W63AyDBEmaqxTz1A2oOzTx1JVQhvRQM69WnTKDMUqUw7x42m6V1GDy82BEp5nmGHv0Fz01ThRhSw8AUEuy9SPEGQ6Yglamc/adPZJYFb4x6tEOIpYgLQnWpJKKCJDcD00R0KRGwqa6oGfzEZteLGPjpZP9Qogd/X04ynJhiToFIqo0+GvSqKWcbEJ8QhxGzR4gfmKR0zU9Pnv1KW4o+38JTK5qzNByftVsXYbNpvLF+qbaqOImuJaM5BIpJmB+Dmh6Z0mMhozpVL/XUp1ZbdOuRaIIyqHBJniGDVG8+mTpr3W9vZ5UDWtEv10PTlvkugT3eby+10jiN/xXbDNA2qK8a9KXAy60c5+PzerPVPm+8Q8v8w5P9jg2tdilqxWlLpufOXIicvw+COeIeRyqX/pS97Zy40qbiFOlQUH6urr0/B1aMQ2mkSiBbCn1SnrSvL6vpJn7JVhxrlXfP7yy5dg3BJBxRh5L31qjcuz496J99srWw+we4sbfM1tMigSmx5avkRKt43NGi6kpumILDt+kUV3yoqezLKCg/EnVqUVB8IOrU/gIU9xtS
qbcpSesVhDV6nLPz
Listen
